Fritextsökning
Innehållstyper
-
Rapid system for surface hygiene monitoring
The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
From planning stage to handshake
"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Irene Svenonius: ”Vi har urstarka förutsättningar att förverkliga målet inom life science"
Finansregionrådet Irene Svenonius (M) tror att Stockholm kan nå målet att höra till världens topp 5 regioner inom life science till år 2025. Och en del i att nå...
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Stärkt skydd för Alzheimerbolag
Alzinova får besked om ytterligare patentskydd på världens största läkemedelsmarknad.
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Beröring från andra är annorlunda
Hjärnan reagerar mycket olika på beröring av någon annan och om man vidrör sig själv. Det visar forskning från Linköpings universitet.
-
Iddo Leshem tar sig an Norden
Iddo Leshem har börjat sin nya roll som general manager för Bristol-Myers Squibb Norden.
-
New management at Øresund
The Øresund University has recently appointed a new director and a new Chairman.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Fyrfaldigad risk för hjärtsvikt hos kvinnor med svår fetma
”Tack vare forskningen minskar dödligheten i hjärt-kärlsjukdom, men våra levnadsvanor riskerar att bryta den positiva trenden”
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Första långverkande behandlingen mot hiv har nått Sverige
En helt ny behandling mot hiv finns nu tillgänglig i Sverige. Istället för de dagliga tabletterna räcker det med sex injektioner per år för att hålla sjukdomen i schack.
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Läkemedel för lupussjuka på väg att ta slut
Trots bristande evidens förskrivs läkemedel med hydroxiklorokin till covid-19-patienter runt om i världen. Nu rapporterar The Guardian att substansen, som är li...